Jorge E. Cortes, MD
Chronic and Acute Myelogenous Leukemia Sections
Department of Leukemia
The University of Texas MD Anderson Cancer Center
Dr. Jorge Cortes received his medical degree from Faculty of Medicine of the National Autonomous University of Mexico, and additional hematology/oncology training at The University of Texas, MD Anderson Cancer Center. He is the Deputy Chair and Chair of the Chronic and Acute Myelogenous Leukemia sections in the Department of Leukemia at the University of Texas MD Anderson Cancer Center.
Dr. Cortes is a worldwide expert in leukemia research, with a unique expertise in clinical and translational research in leukemia, particularly myeloid leukemias. He is program director of the Leukemia Fellowship program, a unique program that he initiated in 2000, and he has mentored more than 25 clinical fellows. In addition, Dr. Cortes has authored more than 800 manuscripts in peer-reviewed journals and is the principal investigator (PI) or co-PI of more than 45 research studies. He has worked on development and approval of new leukemia drugs such as bosutinib, ponatinib, omacetaxine, and others that have completed or are close to completing pivotal trials such as CPX-351, quizartinib, and crenolanib. Dr. Cortes has been recognized with numerous awards for his contributions in the field.